Recent Updates
Recently added Catalysts

QTREX Quantum Ltd.

QTEXFDA catalysts, PDUFA dates & pipeline intelligence
$1.09
▼ -0.06 · -5.22%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full QTEX financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.2852W HIGH $1.65
Volume
2.60 M
Value Traded
2.87 M
Short % Float
6.23%
Days to Cover
1.0
+10.94%Week
-22.14%1 Month
-2.68%3 Month
+178.49%6 Month
-85.46%5 Year
-85.46%All Time

Cash Data

Unlock QTEX cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
61.00 M
EPS (TTM)
-0.45
P/E Ratio
-
Ent. Value
29.99 M
Total Shares
55.96 M
Float Shares
57.42 M
Insiders
14.40%
Institutions
11.46%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every QTEX catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

QTEX Catalyst Timeline

Dated clinical, regulatory and corporate events for QTREX Quantum Ltd.

Unlock the full QTEX catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How QTEX actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all QTEX historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

QTREX Quantum Ltd. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every QTEX program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
HYLA Blood Sensor continuous blood monitoring2025-03-04accuracy: 96%; oxygen deficiency accuracy: 92.3%; patients in study: 6Read MoreInspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a keyRead More
Scroll for more · summaries link to the source press release
Unlock every QTEX trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock QTEX insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Parnes TalDirectorBuy 6,666 766,666 held$1.50 10/15/2026
Unlock the full QTEX insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in QTEX for Q3 2026.
Unlock every fund holding QTEX
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in QTEX
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see QTEX ownership
Insider and institutional ownership, quarter by quarter.

QTEX Short Interest

Shares sold short, counted twice a month.

6.23%
Short % of Float
of tradable shares sold short
3.6M
Shares Sold Short
-16.9% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
5.2M
Avg Daily Volume
the average used for days to cover
Unlock QTEX short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock QTEX option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live QTEX option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock QTEX options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How QTEX ranks across every disease it competes in

Competitive Position is a premium feature
See how QTEX ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

QTEX News

QTEX
Nov 17, 2026
QTEXGeneral
▼ -5.2%on this news

QTREX Acquires GIS to Scale Quantum Interconnect Production, Adding $10 Million in Cash and a Business with $11.3 Million in Revenue

QTREX Quantum Ltd. has acquired Global Inkjet Systems Limited for $16 million, enhancing its production capabilities for quantum computing. The acquisition includes $10 million in cash and $11.3 million in revenue from GIS. This strategic move aims to prepare QTREX for upcoming commercial agreements in the quantum sector. The transaction was completed on November 16, 2026.

Read more →
QTEX
Oct 19, 2026
QTEXGeneral

QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement

QTREX Quantum Ltd. announced it has regained compliance with Nasdaq's minimum bid price requirement. The company achieved this by maintaining a closing bid price of $1.00 or greater for 10 consecutive business days. Nasdaq confirmed that the matter is now closed, allowing QTEX shares to continue trading on the Nasdaq Capital Market.

Read more →
QTEX
Oct 9, 2026
QTEXGeneral
▼ -15.5%on this news

QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

QTREX Quantum Ltd. received a Nasdaq notification for non-compliance with the minimum bid price requirement, as its shares were below $1.00 for 30 consecutive business days. However, the stock has since recovered, trading above $1.00 for six consecutive days. The company has until April 3, 2027, to regain compliance.

Read more →
QTEX
Oct 1, 2026
QTEXGeneral
▲ +15%on this news· ran to +133% by day 3

QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader

QTREX Quantum Ltd. announced successful independent testing of its AME cryogenic interconnect, achieving over 100 dB channel isolation and confirming microwave performance at 20 millikelvin. The results surpassed leading flexible cabling by 60 dB. QTREX is finalizing a definitive agreement with the testing company, to be disclosed soon.

Read more →
QTEX
Sep 24, 2026
QTEXGeneral

QTREX Quantum Reports First Half 2026 Financial Results

QTREX Quantum reported a record revenue of $1.55 million for the first half of 2026, marking a 438% increase from the previous year. The revenue was generated by the AME and Quantum segment shortly after its acquisition. The company launched INSU300, a new material for quantum computing, and anticipates further commercial agreements in the upcoming quarter.

Read more →
QTEX
Sep 2, 2026
QTEXGeneral

One of Israel’s 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum’s AME Technology

QTREX Quantum Ltd. announced that a major defense company has begun deploying its AME technology. The partnership includes exclusive rights and outlines a phased commercial pathway that could generate tens of millions in revenue. The program aims to customize QTREX's technology to meet the partner's stringent requirements.

Read more →
QTEX
Aug 20, 2026
QTEXGeneral
▲ +7.6%on this news

QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares

QTREX Quantum Ltd. announced a $10 million registered direct offering of 11,111,111 ordinary shares. The financing involves an existing institutional investor and a new global investor. The proceeds will be used for working capital and general corporate purposes, with the offering expected to close on August 21, 2026.

Read more →
QTEX
Aug 19, 2026
QTEXGeneral
▲ +24.8%on this newsshared move

QTREX’s Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors

QTREX Quantum Ltd. announced a breakthrough in quantum computing technology, achieving the first direct conversion of 3D-printed insulation into graphene-like carbon. This advancement addresses critical challenges in quantum processors, enhancing protection against stray radiation. The company aims to launch its dielectric material, DF INSU300, by the end of Q3 2026.

Read more →
QTEX
Jun 18, 2026
QTEXGeneral
▲ +5.8%on this news

QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier

QTREX Quantum Ltd. has achieved a significant milestone by producing a cryogenic chip carrier using its proprietary single-build AME process, following a design from a major U.S. technology company. This innovation expands QTREX's involvement within the quantum hardware ecosystem, integrating the chip carrier with the interconnect structure in one architecture. The new capability is expected to enhance signal transport and critical functions around quantum processors, positioning the company to address scaling challenges in future quantum computing systems. QTREX plans to showcase the chip carrier sample during Quantum.Tech World 2026 and tailor designs for specific customer requirements.

Read more →
QTEX
Jun 9, 2026
QTEXGeneral
▲ +13.5%on this news

QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

QTREX Quantum Ltd. has received a grant of approximately $1 million from the Israel Innovation Authority to develop a native RF dielectric material specifically designed for scalable superconducting quantum computing. This material aims to address critical challenges in radio frequency signal routing in cryogenic environments. The grant supports QTREX's vision of advancing its integration of materials and electronics to meet the unique demands of quantum connectivity. CEO Dagi Ben-Noon emphasized that conventional wiring architectures are inadequate for the scaling needs of superconducting quantum processors, underscoring the need for purpose-built solutions in the industry.

Read more →
QTEX
Jun 1, 2026
QTEXGeneral

QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related Materials

QTREX Quantum Ltd. has announced a purchase order from a Fortune 500 company for an Additively Manufactured Electronics (AME) system and related materials. This order is expected to enhance QTREX's commercial footprint in the AME sector, reinforcing its position in advanced technology environments. The AME system will be delivered outside the United States, aiming to provide unique manufacturing capabilities that traditional technologies cannot achieve. CEO Dagi Ben-Noon emphasized the advantages of the AME platform, highlighting the company's growing commercial activity and engagement with tier-1 customers.

Read more →
QTEX
May 29, 2026
QTEXGeneral

Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor

QTREX Quantum Ltd. has announced a $10 million private placement agreement with a fundamental institutional investor for 6,666,667 ordinary shares. The company plans to use the proceeds for working capital and general corporate purposes. The closing of the offering is anticipated around June 1, 2026. Company CEO Dagi Ben-Noon expressed optimism about this funding reinforcing their transition into a quantum hardware infrastructure company and advancing their additively manufactured electronics capabilities.

Read more →
QTEX
May 28, 2026
QTEXGeneral
▲ +42.9%on this newsshared move

Additively Manufactured Electronics and Fabrica Product Lines (Product Lines of Nano Dimension Ltd.) Combined Abbreviated Financial Statements

QTREX Quantum Ltd. has undergone an audit of its financial statements related to the acquisition of certain assets and liabilities from Nano Dimension Ltd.'s Additively Manufactured Electronics and Fabrica product lines. The financial statements reveal a decline in revenues and assets, with significant losses and expenses reported for the years ending December 31, 2024 and 2025. There is considerable uncertainty surrounding the continued viability of the Acquired Operations due to ongoing financial losses and dependence on financial support from the acquiring company.

Read more →
QTEX
May 20, 2026
QTEXGeneral

Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity

Inspira Technologies will start trading under the new ticker symbol 'QTEX' on May 20, 2026, as part of its corporate rebranding to QTREX Quantum Ltd. This change emphasizes the company's strategic focus on its Additively Manufactured Electronics platform, targeting improvements in quantum connectivity infrastructure. The rebranding aligns with Inspira's commitment to developing high-performance electronics solutions for sectors including defense and aerospace. Existing shareholders won't need to take any action during this transition.

Read more →
QTEX
May 18, 2026
QTEXFDA Updates

Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Inspira Technologies has received a $580,000 purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems. This order follows a successful evaluation involving over 30 patients, affirming ART100's operational value in clinical settings. The purchase order marks a transition from evaluation to commercial procurement and enhances Inspira's position in ongoing discussions with other hospital systems. ART100 is currently under evaluation in additional hospitals across the U.S.

Read more →
QTEX
May 11, 2026
QTEXGeneral

Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan Israel, May 11, 2026 -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies,"

Inspira Technologies has issued a letter from CEO Dagi Ben-Noon outlining a comprehensive strategic direction focused on value creation through its Additively Manufactured Electronics (AME) platform and quantum connectivity initiatives. The Company is shifting its operations from legacy medical activities to prioritize scalable revenue generation in high-demand sectors. Recent commercial achievements demonstrate significant interest and ongoing engagements with Tier-1 technology and defense customers. The move to rebrand as QTREX Quantum Ltd. aligns with its ambitious plans within the rapidly evolving quantum computing market.

Read more →
QTEX
May 1, 2026
QTEXGeneral

Inspira Secures $596,000 AME System Order from Leading Irish Technological University

Inspira Technologies has announced a $596,000 purchase order for its Additively Manufactured Electronics (AME) system from a prominent Irish technological university. This order, which includes a 40% non-refundable upfront payment, aims to support the university's advanced research in various cutting-edge domains. The deployment of the system is set to provide Inspira with a recurring revenue model through proprietary consumables and services, reinforcing its commercial strategy. The installation will also serve as a reference point for fostering future engagements with academic and commercial institutions across Europe.

Read more →
QTEX
Apr 30, 2026
QTEXGeneral

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

Inspira Technologies has entered into a Joint Development Agreement with Qarakal Quantum to enhance the performance of superconducting quantum systems. This collaboration focuses on testing Inspira's Additively Manufactured Electronics platform under cryogenic conditions, which is crucial for improving signal connectivity in quantum computing. The structured agreement includes a multi-phase engineering program that aims to address significant challenges in scaling quantum technology. This partnership is a strategic move for Inspira as it expands its capabilities within the quantum computing sector.

Read more →
QTEX
Apr 28, 2026
QTEXGeneral

Technologies Secures Fully Paid $390,000 Order and Recurring Revenue Stream from Premier APAC University

Inspira Technologies has secured a fully paid purchase order worth $390,000 for its additive manufacturing electronics system from a leading Asia-Pacific university. This agreement not only provides immediate revenue but also establishes a recurring revenue stream through consumables and service fees. The AME system is designed to support advanced quantum research, facilitating the development of high-performance electronics crucial for scaling quantum computing systems. Delivery and deployment of the system are scheduled in the coming weeks, accompanied by tailored training for the university's research teams.

Read more →
QTEX
Apr 16, 2026
QTEXGeneral

Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity

Inspira Technologies OXY B.H.N. Ltd. announced the successful deployment of its Additively Manufactured Electronics (AME) system at a Tier-1 U.S. defense customer site. This milestone is seen as a significant achievement that confirms the demand for the AME platform in advanced defense operations and establishes a contractual basis for ongoing revenue. Although the identity of the customer remains undisclosed due to confidentiality, the engagement highlights the strategic importance of Inspira's technology in sectors like quantum computing and superconducting systems. The company expresses optimism about its financial future as this deployment could enhance its growth trajectory.

Read more →

About QTREX Quantum Ltd.

41 employees q-trex.com
HeadquartersRaanana
Founded2017
BIOPHARMAWATCH ELITE
Trade the next QTEX catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime